Hologic Inc (HOLX)

The liquidity ratios of Hologic, Inc. indicate the company's ability to meet its short-term financial obligations. The current ratio has shown a consistent improvement over the past five years, increasing from 1.59 in 2019 to 3.47 in 2023. This signifies that the company has significantly strengthened its ability to cover its short-term liabilities with its current assets.

Similarly, the quick ratio, which provides a more stringent measure of liquidity by excluding inventories from current assets, also demonstrates an upward trend over the same period. The quick ratio increased from 1.24 in 2019 to 2.94 in 2023, indicating an enhanced capacity to meet short-term obligations without relying on selling inventory.

The cash ratio, which measures the company's ability to cover its current liabilities with its cash and cash equivalents, also depicts a positive trajectory. The cash ratio rose from 0.67 in 2019 to 2.43 in 2023, highlighting Hologic's strengthened ability to settle its short-term liabilities with its readily available cash resources.

Overall, the consistent improvement in these liquidity ratios suggests that Hologic, Inc. has enhanced its financial flexibility and ability to meet its short-term obligations over the past five years. This may signify effective management of working capital and a more secure financial position for the company.

---

Additional liquidity measure

The cash conversion cycle is a measure of how efficiently a company can convert its resources and investments into cash flow. Hologic, Inc.'s cash conversion cycle has shown some variation over the past five years, ranging from 116.63 days in 2019 to 161.62 days in 2020. The cash conversion cycle decreased to 127.85 days in 2021 before increasing again to 146.52 days in 2022 and further to 159.26 days in 2023.

A longer cash conversion cycle indicates that the company is taking more time to sell its inventory, collect receivables, and pay its payables, potentially tying up more cash in its operations. Conversely, a shorter cycle implies that the company is able to efficiently manage its working capital and generate cash flow.

It is important for Hologic, Inc. to closely monitor its cash conversion cycle and identify opportunities to improve the efficiency of its working capital management in order to optimize its cash flow and overall financial performance.